Abstract
In this work primarily one-pot synthetic development in the preparation of clopidogrel bisulfate with a polymorphic crystalline form II in 90% yield was developed. This premade antiplatelet drug has been used to protect starch-stabilized silver nanoparticles (AgNPs).
Supplementary Material
Supplemental data for this article can be accessed at the publisher's website.
Funding
The authors are grateful to the Research Council of University of Guilan & Iranian Nanotechnology Initiative Council (INIC) for the financial support of this research work.